A detailed history of Continuum Advisory, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Continuum Advisory, LLC holds 724 shares of EW stock, worth $48,211. This represents 0.01% of its overall portfolio holdings.

Number of Shares
724
Previous 722 0.28%
Holding current value
$48,211
Previous $68,000 2.94%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$84.3 - $94.31 $168 - $188
2 Added 0.28%
724 $66,000
Q1 2024

May 10, 2024

BUY
$72.54 - $95.56 $52,373 - $68,994
722 New
722 $68,000
Q3 2023

Nov 13, 2023

SELL
$69.28 - $93.38 $41,152 - $55,467
-594 Reduced 9.65%
5,560 $385,000
Q2 2023

Dec 13, 2023

BUY
$81.41 - $94.33 $6,187 - $7,169
76 Added 1.25%
6,154 $580,000
Q2 2023

Aug 10, 2023

BUY
$81.41 - $94.33 $6,187 - $7,169
76 Added 1.25%
6,154 $580,000
Q1 2023

Dec 13, 2023

SELL
$74.26 - $84.51 $3,341 - $3,802
-45 Reduced 0.73%
6,078 $502,000
Q1 2023

May 12, 2023

SELL
$74.26 - $84.51 $3,341 - $3,802
-45 Reduced 0.73%
6,078 $502,000
Q4 2022

Dec 13, 2023

SELL
$68.3 - $87.44 $11,201 - $14,340
-164 Reduced 2.61%
6,123 $456,000
Q4 2022

Feb 10, 2023

SELL
$68.3 - $87.44 $11,201 - $14,340
-164 Reduced 2.61%
6,123 $456,000
Q3 2022

Dec 13, 2023

SELL
$82.37 - $107.29 $34,430 - $44,847
-418 Reduced 6.23%
6,287 $519,000
Q3 2022

Nov 08, 2022

SELL
$82.37 - $107.29 $34,430 - $44,847
-418 Reduced 6.23%
6,287 $519,000
Q2 2022

Dec 13, 2023

SELL
$86.5 - $128.27 $1,124 - $1,667
-13 Reduced 0.19%
6,705 $637,000
Q2 2022

Aug 15, 2022

SELL
$86.5 - $128.27 $1,124 - $1,667
-13 Reduced 0.19%
6,705 $638,000
Q1 2022

Dec 13, 2023

SELL
$101.96 - $128.34 $32,321 - $40,683
-317 Reduced 4.51%
6,718 $790,000
Q1 2022

May 17, 2022

SELL
$101.96 - $128.34 $32,321 - $40,683
-317 Reduced 4.51%
6,718 $711,000
Q4 2021

Dec 13, 2023

SELL
$106.37 - $130.68 $5,318 - $6,534
-50 Reduced 0.71%
7,035 $911,000
Q4 2021

Feb 14, 2022

SELL
$106.37 - $130.68 $5,318 - $6,534
-50 Reduced 0.71%
7,035 $911,000
Q3 2021

Dec 13, 2023

SELL
$102.91 - $122.75 $7,821 - $9,329
-76 Reduced 1.06%
7,085 $802,000
Q3 2021

Nov 08, 2021

SELL
$102.91 - $122.75 $7,821 - $9,329
-76 Reduced 1.06%
7,085 $802,000
Q2 2021

Dec 13, 2023

BUY
$83.84 - $104.76 $134,227 - $167,720
1,601 Added 28.79%
7,161 $741,000
Q2 2021

Aug 17, 2021

BUY
$83.84 - $104.76 $600,378 - $750,186
7,161 New
7,161 $742,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.2B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Continuum Advisory, LLC Portfolio

Follow Continuum Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Continuum Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Continuum Advisory, LLC with notifications on news.